Cargando…

The Value of (18)F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

OBJECTIVES: Neoadjuvant chemotherapy (NAC) is the frequently used treatment option for locally advanced breast cancer (LABC). This study investigated the potential value of (18)fluorine-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) to estimate the pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatar, Gamze, Özkul, Özlem, Alçin, Göksel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246305/ https://www.ncbi.nlm.nih.gov/pubmed/35770978 http://dx.doi.org/10.4274/mirt.galenos.2022.44154

Ejemplares similares

Findings of I-131 SPECT/CT, (18)F-FDG, and (68)Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2023)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with (18)F-FDG PET/CT
por: Arslan, Esra, et al.
Publicado: (2022)

Diagnostic Value of (18)F-FDG PET/CT in Patients with Carcinoma of Unknown Primary
por: Cengiz, Arzu, et al.
Publicado: (2018)

Investigation of Clinical Histopathologic Features and Metabolic Parameters of (18)F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component
por: Akgün, Elife, et al.
Publicado: (2023)

Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with (18)F-FDG PET/CT
por: Arslan, Esra, et al.
Publicado: (2022)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Prognostic values of interim and post-therapy (18)F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma
por: Wei, Wen-Xiao, et al.
Publicado: (2015)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

Value of Dynamic (18)F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study
por: Kupik, Osman, et al.
Publicado: (2023)

Prognostic Significance of (18)F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2022)

Prognostic value of (18)F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
por: Han, Sangwon, et al.
Publicado: (2020)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma on (18)F-FDG PET/CT Imaging
por: Cengiz, Arzu, et al.
Publicado: (2018)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses
por: Launay, Nathalie, et al.
Publicado: (2015)

Predictive value of baseline (18)F-FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B-cell lymphoma receiving R-CHOP chemotherapy
por: Zhu, Lili, et al.
Publicado: (2021)

Diagnostic efficacy of (18)F-FDG PET/CT in patients with adrenal incidentaloma
por: Akkuş, Gamze, et al.
Publicado: (2019)

Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Significance of initial, interim and end-of-therapy (18)F-FDG PET/CT for predicting transformation risk in follicular lymphoma
por: Xie, Mixue, et al.
Publicado: (2021)

Diagnostic value of (18)F-FDG-PET/CT in benign lung diseases
por: Ergonul, Ayse Gul, et al.
Publicado: (2018)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
por: Burchardt, Ewa, et al.
Publicado: (2023)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

The Role of Pretreatment (18)F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yao, Jijin, et al.
Publicado: (2021)

Metabolic Radiomics for Pretreatment (18)F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
por: Ha, Seunggyun, et al.
Publicado: (2017)

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
por: Soydal, Çiğdem, et al.
Publicado: (2014)

Metabolic Characteristics and Diagnostic Contribution of (18)F-FDG PET/CT in Gastric Carcinomas
por: Arslan, Esra, et al.
Publicado: (2020)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer
por: Filik, Mustafa, et al.
Publicado: (2015)

Prognostic value of complete metabolic response on (18)F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2022)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fveam2ns6s5k25lilg01gb5vvu